article thumbnail

Navigating FDA Compliance: A Guide to 21 CFR Part 210 and Part 211

Dot Compliance

In the pharmaceutical industry, ensuring the safety and quality of drugs is paramount. Food and Drug Administration (FDA) to meet the Current Good Manufacturing Practice (cGMP) standards. The post Navigating FDA Compliance: A Guide to 21 CFR Part 210 and Part 211 appeared first on Dot Compliance.

FDA 52
article thumbnail

Ketamine is the New Viagra

Bill of Health

By Vincent Joralemon Spravato, the first FDA-approved psychedelic therapy, just outsold Viagra. Remarkably, a therapeutic made from ketamine, once dismissed as a “club drug” or “horse tranquilizer,” now sells more than one of the most notable 21st-century pharmaceuticals. This patent gives someone the motivation to fund FDA trials.

FDA 260
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Monthly Round-Up of What to Read on Pharma Law and Policy

Bill of Health

The selections feature topics ranging from how Wikipedia pages communicate drug efficacy information, to addressing pharmaceutical industry payments to physicians, to the frequency with which the Food and Drug Administration removes hazardous dietary supplements from the market. J Health Polit Policy Law. 2022 Jul 14:10041093.

article thumbnail

California Enters Insulin Manufacturing: Can We Expect to See a California Effect?

Bill of Health

Once approved by the FDA, CalRx insulin will be made available at $30 to all Californians who need it. Increased access to drug pricing data can inform innovation policy decisions on exclusivities, competition, and access for the pharmaceutical industry in general. Insulin is the first product the initiative will manufacture.

article thumbnail

Fluree, Vitality TechNet Partner to Enable Pharma Regulation & Drug Discovery

HIT Consultant

The pharmaceutical industry has long grappled with lengthy timelines and low success rates for new drugs and treatments. But efficient and credible data sharing can spur better processes with the potential to save lives, cut costs, and enable more collaboration across the pharmaceutical industry. years, with only a 7.9%

article thumbnail

Pharma & Influencer Marketing: Can They Coexist Ethically?

HIT Consultant

Mike Szczesny, Owner & VP of EDCO Awards & Specialties Influencer marketing in the pharmaceutical industry is a complex issue with reasonable arguments on multiple sides. According to the FDA’s website , here are some regulations: Ads must be truthful.

article thumbnail

Unlearn Raises $50 Million Series C to Optimize Clinical Research With AI-Powered Digital Twin Technology

Healthcare IT Today

Unlearn’s technology powers the clinical trials of leading global pharmaceutical companies, helping them to reach full enrollment faster and bring new treatments to patients sooner. Their methods using participants’ digital twins are qualified by the European Medicines Agency and align with current FDA guidance.